Viguier M - Search Results

1

MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis.

Hemon P, Jean-Louis F, Ramgolam K, Brignone C, Viguier M, Bachelez H, Triebel F, Charron D, Aoudjit F, Al-Daccak R, Michel L. Hemon P, et al. Among authors: viguier m. J Immunol. 2011 May 1;186(9):5173-83. doi: 10.4049/jimmunol.1002050. Epub 2011 Mar 25. J Immunol. 2011. PMID: 21441454

2

Clinical and histopathologic features and immunologic variables in patients with severe chilblains. A study of the relationship to lupus erythematosus.

Viguier M, Pinquier L, Cavelier-Balloy B, de la Salmonière P, Cordoliani F, Flageul B, Morel P, Dubertret L, Bachelez H. Viguier M, et al. Medicine (Baltimore). 2001 May;80(3):180-8. doi: 10.1097/00005792-200105000-00004. Medicine (Baltimore). 2001. PMID: 11388094 Free article. Clinical Trial.

3

HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED. Aractingi S, et al. Among authors: viguier m. Am J Pathol. 2001 Jul;159(1):71-7. doi: 10.1016/S0002-9440(10)61675-6. Am J Pathol. 2001. PMID: 11438456 Free PMC article.

4

B-cell lymphomas involving the skin associated with hepatitis C virus infection.

Viguier M, Rivet J, Agbalika F, Kerviler E, Brice P, Dubertret L, Bachelez H. Viguier M, et al. Int J Dermatol. 2002 Sep;41(9):577-82. doi: 10.1046/j.1365-4362.2002.01603.x. Int J Dermatol. 2002. PMID: 12358827

5

[Cutaneous B-cell lymphoma treatment with rituximab: two cases].

Viguier M, Bachelez H, Brice P, Rivet J, Dubertret L. Viguier M, et al. Ann Dermatol Venereol. 2002 Oct;129(10 Pt 1):1152-5. Ann Dermatol Venereol. 2002. PMID: 12442128 French.

6

Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy.

Viguier M, Fouéré S, de la Salmonière P, Rabian C, Lebbe C, Dubertret L, Morel P, Bachelez H. Viguier M, et al. Medicine (Baltimore). 2003 Mar;82(2):82-6. doi: 10.1097/00005792-200303000-00002. Medicine (Baltimore). 2003. PMID: 12640184 Free article.

7

[Psoriasis].

Viguier M, Bachelez H. Viguier M, et al. Rev Prat. 2003 Jan 1;53(1):75-80. Rev Prat. 2003. PMID: 12673929 French. No abstract available.

8

Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).

Michel L, Dupuy A, Jean-Louis F, Sors A, Poupon J, Viguier M, Musette P, Dubertret L, Degos L, Dombret H, Bachelez H. Michel L, et al. Among authors: viguier m. J Invest Dermatol. 2003 Oct;121(4):881-93. doi: 10.1046/j.1523-1747.2003.12479.x. J Invest Dermatol. 2003. PMID: 14632209 Free article. Clinical Trial.

9

Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).

Dupuy A, Viguier M, Bédane C, Cordoliani F, Blaise S, Aucouturier F, Bonnetblanc JM, Morel P, Dubertret L, Bachelez H. Dupuy A, et al. Among authors: viguier m. Arch Dermatol. 2004 Jan;140(1):91-6. doi: 10.1001/archderm.140.1.91. Arch Dermatol. 2004. PMID: 14732665

10

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

Viguier M, Lemaître F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L. Viguier M, et al. J Immunol. 2004 Jul 15;173(2):1444-53. doi: 10.4049/jimmunol.173.2.1444. J Immunol. 2004. PMID: 15240741

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page